Articles related to GLP-1 RECEPTOR AGONISTS

Patients on GLP-1 medications may experience notable changes in breast morphology, such as decreased volume and increased sagging. Medical experts recommend supportive measures and a stable weight before considering surgical interventions.

Ozempic, commonly used off-label for weight management, can cause significant facial side effects, termed “Ozempic face,” marked by increased wrinkling and loss of skin elasticity.

Recent studies suggest that GLP-1 receptor agonists, while primarily used for weight loss, may also impact mental health and behavior, potentially due to their effects on the brain’s reward systems.

The multifaceted approach to obesity management is discussed in Oprah Winfrey’s latest TV special, where GLP-1 medications and the call for empathy in patient care take center stage, offering new perspectives on treatment and patient engagement.

Physicians should be vigilant about the dual impact of GLP-1 drugs on contraceptive failure and unexpected fertility enhancements, prompting a reassessment of patient guidance and contraceptive choices in clinical practice.

Stay informed about the potential risks associated with popular weight loss drugs. Ensure patient safety by monitoring for symptoms of depression and suicidal ideation.